CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 99 enrolled
Drug / intervention
Channel Esophagogastrostomy +1 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06741124
NCT06741124N/ACompleted
CompareCT.gov

Comparison of Channel Esophagogastrostomy and Double Tract Reconstruction After Laparoscopic-assist Proximal Gastrectomy: A Propensity Score-Matched Analysis

Northern Jiangsu People's Hospital·observational·Posted Dec 18, 2024·Updated Jan 10, 2025

In Brief

An observational study evaluating Channel Esophagogastrostomy and Double Tract Reconstruction for Gastric (Stomach) Cancer. Completed, enrolled 99 participants across 1 site.

Detailed Summary

This retrospective cohort study enrolled adult patients who underwent LAPG between September 2020 and September 2023 at Northern Jiangsu People's Hospital. Patients were categorized into the CE group (CE anastomosis) and the DTR group (DTR anastomosis) based on the digestive tract reconstruction method after LAPG. Variables such as sex and BMI may influence the technical difficulty and clinical outcomes of LAPG. To minimize bias, propensity score (PS) matching was performed at a 1:2 ratio between the CE group and the DTR group.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastric (Stomach) Cancer
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedDec 18, 2024
Enrollment StartSep 1, 2020
Primary CompletionSep 1, 2023
Study CompletionSep 1, 2024
TodayJul 2, 2026
Enrollment to primary: 3 yearsPosted 1.5 years ago

Interventions

Channel Esophagogastrostomyprocedure

Channel Esophagogastrostomy

Double Tract Reconstructionprocedure

Double Tract Reconstruction